[1]刘 珊,敬秀平△.苏子降气汤加减联合西药治疗老年慢性阻塞性肺疾病急性加重期疗效研究*[J].陕西中医,2020,(12):1739-1742.[doi:DOI:10.3969/j.issn.1000-7369.2020.12.015]
　LIU Shan,JING Xiuping..Effect of modified Suzi Jiangqi decoction combined with western medicine on elderly patients with acute exacerbation of chronic obstructive pulmonary disease[J].,2020,(12):1739-1742.[doi:DOI:10.3969/j.issn.1000-7369.2020.12.015]
点击复制

苏子降气汤加减联合西药治疗老年慢性阻塞性肺疾病急性加重期疗效研究*
分享到：

《陕西中医》[ISSN:1000-7369/CN:61-1281/TN]

卷:
期数:
2020年12期
页码:
1739-1742
栏目:
临床研究
出版日期:
2020-12-05

文章信息/Info

Title:
Effect of modified Suzi Jiangqi decoction combined with western medicine on elderly patients with acute exacerbation of chronic obstructive pulmonary disease
作者:
刘 珊; 敬秀平△
四川省广安市人民医院(广安 638000)
Author(s):
LIU Shan; JING Xiuping.
Guang'an People's Hospital in Sichuan Province(Guang'an 638000)
关键词:
苏子降气汤;  老年慢性阻塞性肺疾病;  急性加重期;  血清D-二聚体;  超敏C反应蛋白;  肺功能
Keywords:
Suzi Jiangqi decoction;  Chronic obstructive pulmonary disease in the elderly;  Acute exacerbation;  Serum D-Diner;  High sensitivity C-reactive protein;  Lung function
分类号:
R256.1
DOI:
DOI:10.3969/j.issn.1000-7369.2020.12.015
文献标志码:
A
摘要:
目的:探讨苏子降气汤加减联合西药治疗老年慢性阻塞性肺疾病(COPD)急性加重期患者疗效及对血清D-二聚体(D-D)、超敏C反应蛋白(hs-CRP)的影响。方法:120例老年COPD急性加重期患者,将编号为奇数者纳入对照组(n=60),编号为偶数者纳入研究组(n=60)。两组都给予常规治疗,对照组在常规治疗基础上采用多索茶碱静滴,研究组在对照组基础上联合苏子降气汤加减治疗。比较两组疗效,患者血清D-D、hs-CRP的水平。结果:研究组总有效率93.33%,对照组总有效率76.67%,两组比较差异有统计学意义(P<0.05)。治疗后研究组中医症状积分低于对照组(P<0.05)。研究组治疗后血沉、降钙素原、血清D-D、纤维蛋白原水平均低于对照组(P<0.05)。治疗后两组第1秒用力呼气容积、用力肺活量均升高,FEV1/FVC水平降低,且研究组治疗后FEV1、FVC高于对照组,FEV1/FVC低于对照组,差异有统计学意义(P<0.05)。结论:苏子降气汤加减联合西药治疗能改善老年COPD急性加重期患者中医证候、凝血功能及肺功能,减轻炎症反应,疗效较好。
Abstract:
Objective:To investigate the effect of modified Suzi Jiangqi decoction combined with western medicine on serum D-Diner(D-D)and high sensitivity C-reactive protein(hs-CRP)in elderly patients with acute exacerbation of chronic obstructive pulmonary disease(COPD).Methods:120 elderly patients with acute exacerbation of COPD were selected.Those with odd numbers were included in the control group(n= 60)and those with even numbers in the study group(n= 60).Both groups were given conventional treatment.On this basis,the control group was treated with intravenous drip of doxofylline,while the study group was treated with modified Suzi Jiangqi decoction combined with intravenous drip of doxofylline.Clinical effects were comparatively analyzed,and effects of different treatment methods on serum D-D and hs-CRP were analyzed.Results:The total effective rate was 93.33% in the study group and 76.67% in the control group,significant difference(P<0.05).After treatment,TCM symptom scores of the study group were significantly lower than those of the control group(P<0.05).The levels of hs-CRP,erythrocyte sedimentation rate,procalcitonin,serum D-D and fibrinogen in the study group were significantly lower than those in the control group(P<0.05).After treatment,the forced expiratory volume in 1 second(FEV1)and forced vital capacity of the two groups significantly increased,while FEV1/FVC decreased.Besides,FEV1 and FVC in the study group were significantly higher than those in the control group,and FEV1/FVC was lower than that in the control group,significant difference(P<0.05).Conclusion:Modified Suzi Jiangqi decoction combined with western medicine can significantly improve TCM symptoms,blood coagulation function and lung function in elderly patients with acute exacerbation of COPD while reliving inflammation,with better curative effects.

参考文献/References:

[1] 谢文英,司春婴,尚立芝,等.爱罗咳喘宁对老年COPD急性加重期痰湿阻肺证患者血清中细胞因子及肺功能的影响[J].中国实验方剂学杂志,2015,21(12):143-146.
[2] 于维霞.苓桂咳喘宁胶囊辅助治疗慢性阻塞性肺疾病急性加重期痰湿阻肺证疗效及对血清炎症因子和免疫功能的影响[J].中华中医药学刊,2018,36(6):1530-1533.
[3] 钱俊峰,王洪源,徐 芳,等.喘可治注射液联合舒利迭对老年COPD急性加重期患者T淋巴细胞亚群、炎症介质和凝血功能的影响[J].中国老年学杂志,2018,38(20):4930-4932.
[4] 樊贞玉,胡咏泉,卢献灵,等.布地奈德雾化吸入治疗对老年慢性阻塞性肺疾病急性加重期患者肺功能、降钙素原和C反应蛋白水平的影响[J].中国老年学杂志,2017,37(19):4832-4833.
[5] 中华医学会呼吸病学分会慢性阻塞性肺疾病学组.慢性阻塞性肺疾病诊治指南[J].中华内科杂志,2002,25(8):453-460.
[6] 国家中医药管理局.中药新药临床研究指导原则[M].北京:中国医药科技出版社,2002:68-73.
[7] 中华医学会呼吸病学分会慢性阻塞性肺疾病学组.COPD诊治指南(2007年修订版)[J].继续医学教育,2007,21(2):31-42.
[8] 张胜睿,杨栋梁,匡智明,等.重症慢性阻塞性肺疾病急性发作期患者血清D-二聚体、超敏C反应蛋白及降钙素原表达及其临床意义[J].中国老年学杂志,2019,39(5):1084-1086.
[9] 陈四清,谢文英,尚立芝,等.二陈汤加味对慢性阻塞性肺疾病急性加重期老年患者免疫功能及CCL18,CC16,IL-8和sICAM-1的影响[J].中国实验方剂学杂志,2017,23(10):171-177.
[10] 李三喜,赵 涛,谢昌鸿,等.参麦注射液联合舒利迭治疗老年COPD患者的疗效及对血清GM-CSF、NF-κB、LTB4的影响[J].中成药,2018,40(12):2818-2821.
[11] 席 瑞,张邹阳,张 亮,等.血必净协同治疗对于慢性阻塞性肺疾病急性加重期患者临床肺部感染评分、炎症标记物及免疫功能的影响[J].中华中医药学刊,2017,35(5):1240-1242.
[12] 蔡昕姝,薛运昕,谭明旗,等.布地奈德及特布他林联合噻托溴铵对老年慢性阻塞性肺疾病急性加重期患者肺功能的影响[J].中国老年学杂志,2020,40(6):1218-1220.
[13] 刘志刚,孙宜芬,孟红旗,等.苏子降气汤治疗慢性阻塞性肺病急性加重疗效观察[J].临床肺科杂志,2016,21(8):1442-1444,1445.
[14] 陈明锦,陈永堂.苏子降气汤加味联合西药治疗急性加重期COPD疗效分析[J].浙江临床医学,2018,20(9):1501-1503.
[15] 张 芳.特布他林联合清肺化痰汤治疗老年COPD疗效观察[J].陕西中医,2018,39(5):580-583.
[16] 李静静.肾上腺皮质激素配合特布他林诊治急性加重慢阻肺效果及对患者肺通气功能影响评价[J].中国急救医学,2018,38(10):23.
[17] 陈元菁,王湘云,艾红军,等.雾化特布他林联合布地奈德治疗急性加重期慢性阻塞性肺疾病的临床疗效及对炎性因子的影响[J].山西医药杂志,2019,48(13):1531-1534.
[18] 王 媛,张华丽,张 勇,等.COPD急性加重期患者血清SAA、PCT、hs-CRP水平变化及意义[J].陕西医学杂志,2015,44(5):616-617,637.
[19] 刘晗念,郑承红,丁 念,等.苏子降气汤治疗慢性阻塞性肺疾病急性加重期的荟萃分析[J].吉林中医药,2019,39(10):1325-1330.
[20] 张慧俭.苏子降气汤加味治疗缓解期老年慢性阻塞性肺疾病[J].中医学报,2019,34(2):361-365.
[21] 郑文江,彭紫荆,洪 榆,等.苏子降气汤加减治疗慢性阻塞性肺疾病急性加重期的系统评价和Meta分析[J].中药新药与临床药理,2019,30(12):1534-1541.
[22] 郑 忻,曲妮妮,马丽佳,等.苏子降气汤对慢性阻塞性肺疾病急性发作期(痰浊壅肺证)肺功能的影响及部分机制[J].世界中医药,2018,13(6):1487-1491.

备注/Memo

备注/Memo:
*四川省医学会科研课题(Q1504017)
更新日期/Last Update: 2020-12-11